Recent News

• 04.09.2025 - Jones Healthcare and Technology Innovation Conference 2025
• 04.09.2025 - Jones Healthcare and Technology Innovation Conference 2025
• 03.31.2025 - IN8bio to Present New Preclinical Data on Novel Gamma-Delta (γδ) T cell Engager Platform for Cancer Immunotherapy at AACR Annual Meeting 2025
• 03.31.2025 - IN8bio to Present New Preclinical Data on Novel Gamma-Delta (γδ) T cell Engager Platform for Cancer Immunotherapy at AACR Annual Meeting 2025
• 03.18.2025 - IN8bio to Participate at the 11th Annual Immuno-Oncology 360° Conference 2025
• 03.18.2025 - IN8bio to Participate at the 11th Annual Immuno-Oncology 360° Conference 2025
• 03.13.2025 - IN8bio Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
• 03.13.2025 - IN8bio Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
• 03.03.2025 - TD Cowen 45th Annual Health Care Conference
• 03.03.2025 - TD Cowen 45th Annual Health Care Conference

Recent Filings

• 03.17.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 03.17.2025 - ARS Annual Report to Security Holders
• 03.17.2025 - DEF 14A Other definitive proxy statements
• 03.13.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.13.2025 - EX-99.1 EX-99.1
• 03.13.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.13.2025 - 8-K Current report
• 03.05.2025 - 8-K Current report
• 03.05.2025 - PRE 14A Other preliminary proxy statements